Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Flanders

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA Neurology|May 18, 2026
Methodological Considerations for Quantile Aggregation in Alzheimer Disease TrialsMichael D Flanders, Michelle Caunca, Renaud La Joie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 17, 2026
Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual-level data from the A4 study of solanezumabSarah F Ackley, Michael D Flanders, Audrey Murchland, et al.
Leukemia & Lymphoma|October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remissionGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Nature Medicine|June 25, 2013
Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune controlSrinika Ranasinghe, Sam Cutler, Isaiah Davis, et al.
The Journal of Clinical Investigation|August 28, 2012
Expansion of HIV-specific T follicular helper cells in chronic HIV infectionMadelene Lindqvist, Jan van Lunzen, Damien Z Soghoian, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Neurology|May 18, 2026
Methodological Considerations for Quantile Aggregation in Alzheimer Disease TrialsMichael D Flanders, Michelle Caunca, Renaud La Joie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 17, 2026
Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual-level data from the A4 study of solanezumabSarah F Ackley, Michael D Flanders, Audrey Murchland, et al.
Leukemia & Lymphoma|October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remissionGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Nature Medicine|June 25, 2013
Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune controlSrinika Ranasinghe, Sam Cutler, Isaiah Davis, et al.
The Journal of Clinical Investigation|August 28, 2012
Expansion of HIV-specific T follicular helper cells in chronic HIV infectionMadelene Lindqvist, Jan van Lunzen, Damien Z Soghoian, et al.
Pageof 1